Unresectable hepatocellular carcinoma treatment with doxorubicin-eluting polyethylene glycol microspheres: a single-center experience.

Gerardo Tovar-FeliceAndrés García-GámezVirgilio Benito-SantamaríaDavid Balaguer-PaniaguaJordi Villalba-AuñónJaume Sampere-Moragues

Published in: Hepatic oncology (2021)

Doxorubicin-loaded LifePearl™ TACE might be an effective treatment, with a good safety profile, for patients with early/intermediate-stage hepatocellular carcinoma. Further prospective data, especially with a small cohort of selected patients, are required to confirm these results.

Keyphrases

drug delivery
end stage renal disease
cancer therapy
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
combination therapy
radiation therapy
artificial intelligence
locally advanced
liver metastases
simultaneous determination
rectal cancer
deep learning
molecularly imprinted